Concepedia

Publication | Open Access

Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study)

DOIFull Paper Access

61

Citations

13

References

2020

Year

Hironaga Satake, Takeshi Kato, Koji Oba, Masahito Kotaka, Yoshinori Kagawa, Hisateru Yasui, Masato Nakamura, Takanori Watanabe, Toshihiko Matsumoto, Takayuki Kii,
The Oncologist

Abstract

Biweekly TAS-102 plus BEV showed promising antitumor activity with safety.

References

YearCitations

Page 1